Cargando…
Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features
Background: Hypoxia is recognized as a key feature of cancer growth and is involved in various cellular processes, including proliferation, angiogenesis, and immune surveillance. Besides hypoxia-inducible factor 1-alpha (HIF-1α), which is the main mediator of hypoxia effects and can also be activate...
Autores principales: | Vlachostergios, Panagiotis J., Tamposis, Ioannis A., Anagnostou, Maria, Papathanassiou, Maria, Mitrakas, Lampros, Zachos, Ioannis, Thodou, Eleni, Samara, Maria, Tzortzis, Vassilios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689673/ https://www.ncbi.nlm.nih.gov/pubmed/36421334 http://dx.doi.org/10.3390/curroncol29110681 |
Ejemplares similares
-
Current Options for Second-Line Systemic Therapy in Metastatic Renal Cell Carcinoma
por: Mitsogiannis, Iraklis C., et al.
Publicado: (2022) -
Characterization of a miRNA Signature with Enhanced Diagnostic and Prognostic Power for Patients with Bladder Carcinoma
por: Samara, Maria, et al.
Publicado: (2023) -
DNA Repair Gene Polymorphisms and Susceptibility to Urothelial Carcinoma in a Southeastern European Population
por: Samara, Maria, et al.
Publicado: (2021) -
Upper Tract Urothelial Carcinoma: A Rare Malignancy with Distinct Immuno-Genomic Features in the Era of Precision-Based Therapies
por: Evmorfopoulos, Konstantinos, et al.
Publicado: (2023) -
Immune-based treatment re-challenge in renal cell carcinoma: A systematic review and meta-analysis
por: Papathanassiou, Maria, et al.
Publicado: (2022)